Quantum Biopharma Provides Corporate Update

Toronto-based Quantum Biopharma Ltd. has announced several significant company updates. The biopharmaceutical company has granted 29,500 stock options to directors, officers, employees, and consultants. Options vest immediately, priced at CA$5.25, and are exercisable for two years. A related-party transaction involving a director was disclosed, but it meets exemption criteria under MI 61-101 regulations.

Moreover, the company has secured the services of Cambridge Consultants Inc., TD Media LLC, and King Tide Media LLC to enhance market awareness. Each engagement is set for a one-month term starting October 7, 2024, and can be terminated with ten days' notice. The agreements cost US$35,000, US$75,000, and US$50,000 respectively.